Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Antiviral Strategies

H.-G. Krausslich, R, Bartenschlager (eds,). Antiviral Strategies, Handbook of Experimental 1 Pharmacology 189,... [Pg.1]

The antiviral strategies discussed earlier as well as all antiviral drugs available to date are based on the principles of conventional chemotherapy. However, recent discoveries and developments in molecular biology have opened perspectives for alternative approaches of intervention. [Pg.17]

Kleimnan et al. 2008). In addition, synthetic siRNAs are also subject to degradation in vivo by nuclease activity. Besides side effects and instability, the efficient and specific delivery of the RNAi indncers to the target cell still requires optimization. Here we snmmarize the cnrrent statns of nncleic acid-based antiviral therapentics. The focns will be on antiviral strategies nsing antisense and RNAi technology. Additionally, antiviral ribozymes and aptamers will be discussed briefly, with a focus on recent studies. Gene therapy approaches and delivery systems are the subject of Chapter 11 of this book. [Pg.246]

Fig. 2 RNAi inducers used in antiviral strategies. In general, RNAi is induced either by transfection of synthetic siRNAs into cells, or by stable or transient intracellular expression of double-stranded siRNA precursors (shRNA, e-shRNA, IhRNA, or pri-miRNAs). After transcription in the nucleus shRNAs, IhRNAs and e-shRNAs are exported to the cytoplasm and subsequently diced into mature siRNAs. Pri-miRNAs modified to encode antiviral siRNAs first undergo cleavage by Drosha before they are exported to the cytoplasm. Here the antiviral pre-miRNAs (also called shRNA-miRs) are processed by Dicer into the mature miRNAs. After loading of the antisense strand of the siRNAs/miRNAs into RISC, the complex will target and cleave viral transcripts bearing the complementary sequences... Fig. 2 RNAi inducers used in antiviral strategies. In general, RNAi is induced either by transfection of synthetic siRNAs into cells, or by stable or transient intracellular expression of double-stranded siRNA precursors (shRNA, e-shRNA, IhRNA, or pri-miRNAs). After transcription in the nucleus shRNAs, IhRNAs and e-shRNAs are exported to the cytoplasm and subsequently diced into mature siRNAs. Pri-miRNAs modified to encode antiviral siRNAs first undergo cleavage by Drosha before they are exported to the cytoplasm. Here the antiviral pre-miRNAs (also called shRNA-miRs) are processed by Dicer into the mature miRNAs. After loading of the antisense strand of the siRNAs/miRNAs into RISC, the complex will target and cleave viral transcripts bearing the complementary sequences...
Clinical Trials Involving Intracellular Antiviral Strategies.278... [Pg.265]

In conclusion, we hope that this volume will be valued by researchers in the field, and by those who are engaged in the future developments and applications of antiviral strategies. [Pg.385]


See other pages where Antiviral Strategies is mentioned: [Pg.200]    [Pg.201]    [Pg.201]    [Pg.1]    [Pg.1]    [Pg.1]    [Pg.3]    [Pg.5]    [Pg.7]    [Pg.9]    [Pg.10]    [Pg.11]    [Pg.12]    [Pg.13]    [Pg.15]    [Pg.17]    [Pg.17]    [Pg.19]    [Pg.21]    [Pg.23]    [Pg.44]    [Pg.80]    [Pg.249]    [Pg.272]    [Pg.272]    [Pg.273]    [Pg.278]    [Pg.323]    [Pg.184]    [Pg.186]   


SEARCH



© 2024 chempedia.info